Skip to main content
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;30(5):310–317. [Article in Spanish] doi: 10.1016/S0212-6567(02)79033-1

Recomendaciones en el abordaje diagnóstico y terapéutico del fumador. Documento de consenso

M Torrecilla García a,*, F Domínguez Grandal a, A Torres Lana a, C Cabezas Peña a, CA Jiménez Ruiz b, M Barrueco Ferrero b, S Solano Reina b, JI de Granda Orive b, JL Díaz-Maroto Muñoz c, J Alonso c, ML Martínez c, S García c, E de la Cruz Amorós d, R Abengozar Muela d, F Ramos Postigo d, J Ayesta d
PMCID: PMC7684189  PMID: 12372213

The content is available as a PDF (331.9 KB).

Bibliografía

  • 1.Encuesta nacional sobre el hábito de fumar. Ministerio de Sanidad y Consumo. Dirección General de Salud Pública; Madrid; 1995. [Google Scholar]
  • 2.The Smoking Cessation Clinical practice guideline Panel and staff. The Agency for Health Care Policy and research. Smoking cessation clinical practice guideline. JAMA. 1996;275:1270–1280. [PubMed] [Google Scholar]
  • 3.Banegas Banegas J.R., Díez Gañán L., Rodríguez-Artalejo F., González Enríquez J., Graciani A., Villar F. Mortalidad atribuible al tabaquismo en España en 1998. Med Clin (Barc) 2001;117:692–694. doi: 10.1016/s0025-7753(01)72226-9. [DOI] [PubMed] [Google Scholar]
  • 4.Fiore M.C, Bailey W.C, Cohen S.J, Dorfman S.F, Goldstein M.G, Gritz E.R, Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service, junio 2000.
  • 5.Fiore M.C., Jorenby D.E., Schnsky A.E., Smith S.S., Bauer R.R., Baker T.B. Smoking status as the new vital sign: effect on assessment and intervention in patients who smoke. Mayo Clin Proc. 1995;70:209–213. doi: 10.4065/70.3.209. [DOI] [PubMed] [Google Scholar]
  • 6.Mcbride P.E., Plane M.B., Underbakke G., Brown R.L., Solberg L.I. Smoking screening and management in primary care practices. Arch Fam Med. 1997;6:165–172. doi: 10.1001/archfami.6.2.165. [DOI] [PubMed] [Google Scholar]
  • 7.Doll R., Crofton J. Tobacco and health. Br Med Bull. 1996;52:12–23. [Google Scholar]
  • 8.US Department of Health Human Services . The health consequences of smoking: cancer. A report of the Surgeon General. US Department of Health and Human Services; Washington DC: 1982. DHHS. Publ. PHS 82–50179. [Google Scholar]
  • 9.Burrows B., Knudson R.J., Camilli A.E., Stiezer M., Nett L.A., Lando H. Quantitative relationship between cigarette smoking and ventilatory function. Am Rev Respir Dis. 1988;137:286–292. doi: 10.1164/arrd.1977.115.2.195. [DOI] [PubMed] [Google Scholar]
  • 10.Jarvis M.J. Patterns and predictors of smoking in the general population. In: Bolliger CT, Fagerström KO, editors. The tobacco epidemic. Basel, Karger: Prog Respir Res. 1997;28:151–164. [Google Scholar]
  • 11.Jarvis M.J. Gender differences in smoking cessation: real or myth? Tob Control. 1994;3:324–328. doi: 10.1136/tobaccocontrol-2011-050279. [DOI] [PubMed] [Google Scholar]
  • 12.Prochazka J., DiClemente C. Stages and process of self-change of smoking: towards an integrative model of change. J Clin Psychol. 1983;3:390–395. doi: 10.1037//0022-006x.51.3.390. [DOI] [PubMed] [Google Scholar]
  • 13.Jiménez Ruiz C.A., Solano S., González J.M., Ruiz M., Flórez S., Ramos A. Recomendaciones para el tratamiento del tabaquismo. Arch Bronconeumol. 1999;335:499–506. doi: 10.1016/s0300-2896(15)30025-9. [DOI] [PubMed] [Google Scholar]
  • 14.Fagerström K.O., Schneider N. Measuring nicotine dependence: a review of the FTND. J Behav Med. 1989;12:159–182. doi: 10.1007/BF00846549. [DOI] [PubMed] [Google Scholar]
  • 15.Heatherton T.F., Kozlowsky L.T., Frecker R.C., Baker T., Whisler W., Fagerström K.O. The Fagerström Test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86:1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x. [DOI] [PubMed] [Google Scholar]
  • 16.Tonnesen P. Nicotine replacement and other drugs in smoking cessation. En: Bolliger CT, Fagerström KO, editors. The tobacco epidemic. Basel, Karger: Prog Respir Res. 1997;28:178–189. [Google Scholar]
  • 17.Silagy C., Mant D., Fowler G., Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet. 1994;343:139–142. doi: 10.1016/s0140-6736(94)90933-4. [DOI] [PubMed] [Google Scholar]
  • 18.Tonnesen P. Kluwer; Amsterdam: 1994. Smoking cessation programs. In: Hansen HH, editor. Lung Cancer; pp. 75–89. [Google Scholar]
  • 19.Kunze M. Harm reduction: the possible role of nicotine replacement. In: Bolliger CT, Fagerström KO, editors. The tobacco epidemic. Basel, Karger: Prog Respir Res. 1997;28:190–198. [Google Scholar]
  • 20.Jiménez Ruiz C.A., Masa F., Miravitlles M., Gabriel R., Viejo J.L., Villasante C. Smoking characteristics: differences in attitudes and dependence between healthy smokers an smokers with COPD. Chest. 2001;119:1365–1370. doi: 10.1378/chest.119.5.1365. [DOI] [PubMed] [Google Scholar]
  • 21.Jarvis J., Russell M.A.H. Expired air CO: a simple breath of tobacco smoke intake. BMJ. 1980;281:484–485. doi: 10.1136/bmj.281.6238.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Clark K.D., Wardrobe-Wong N., Eliot J.J., Priece T., Lindens T., Larstrom B. Cigarrette smoke inhalation and lung damage in smokers volunteers. Eur Respir J. 1998;12:395–399. doi: 10.1183/09031936.98.12020395. [DOI] [PubMed] [Google Scholar]
  • 23.Zacny J.P., Stitzer M.L., Browh F.J., Brown F.H., Prawn H.N., Lawn H.J. Human cigarette smoking: effect od puff and inhalation parameters on smoke exposure. J Pharmacol Exp Ther. 1986;240:554–564. [PubMed] [Google Scholar]
  • 24.Wald N.J., Howard S., Smith P.G., Kjeldsen K. Association between atherosclerotic disease and carboxyhaemoglobin levels in tobacco smoke. BMJ. 1973:761–765. doi: 10.1136/bmj.1.5856.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Prochaska J., Goldstein M. Process of smoking cessation. Implications for clinicians. Clin Chest Med. 1991;12:727–735. [PubMed] [Google Scholar]
  • 26.Silagy C. Update software; Oxford: 2001. Physician advice for smoking cessation. Cochrane Library N 2. [DOI] [PubMed] [Google Scholar]
  • 27.Lancaster T., Stead L.F. Update software; Oxford: 2001. Individual behavioural counselling for smoking cessation. Cochrane Library N 2. [Google Scholar]
  • 28.Rice V.H., Stead L.F. Update software; Oxford: 2001. Nursing interventions for smoking cessation. Cochrane Library. N 2. [DOI] [PubMed] [Google Scholar]
  • 29.Lancaster T., Stead L.F. Update software; Oxford: 2002. Self-help interventions for smoking cessation. Cochrane Library. N 2. [DOI] [PubMed] [Google Scholar]
  • 30.Jiménez Ruiz C.A., Solano S., Barrueco M., De Granda J.I., Lorza J.J., Alonso S. Recomendaciones para la organización y funcionamiento de las unidades especializadas en tabaquismo. Arch Bronconeumol. 2001;37:382–387. doi: 10.1016/s0300-2896(01)78819-9. [DOI] [PubMed] [Google Scholar]
  • 31.Jiménez Ruiz C.A., Ayesta J., Planchuelo M.A., Abéngozar R., Torrecilla M., Quintas A.M. Recomendaciones de la Sociedad Española de Especialistas en Tabaquismo para el tratamiento farmacológico del tabaquismo. Prev Tab. 2001;3:78–85. [Google Scholar]
  • 32.Silagy C., Mant D., Lancaster T., Stead L., Mant D., Fowler G. Update software; Oxford: 2001. Nicotine replacement therapy for smoking cessation. Cochrane Library. N 2. [DOI] [PubMed] [Google Scholar]
  • 33.Hughes J.R., Stead L.F., Lacaster T. Update software; Oxford: 2001. Anxiolytics and antidepressants for smoking cessation. Cochrane Library. N 2. [DOI] [PubMed] [Google Scholar]
  • 34.US Department of Health Human Services Public Health Service. Clinical practice guideline: treating tobacco use and dependence. Washington, junio 2000.

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES